First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen P Anthony, DO
Sumitomo Pharma America, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Arizona
Phoenix, Arizona, United States
- Honorhealth Research Institute
Scottsdale, Arizona, United States
- Us Oncology - Rocky Mountain Cancer Centers, Llp (rmcc)
Denver, Colorado, United States
- University of Colorado Denver
Denver, Colorado, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Miami Cancer Institute
Miami, Florida, United States
- University of Kansas Cancer Center
Fairway, Kansas, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Us Oncology - Willamette Valley Cancer Institute and Research Center
Eugene, Oregon, United States
- Us Oncology - Texas Oncology Austin
Austin, Texas, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Us Oncology - Texas Oncology - Fort Worth
Fort Worth, Texas, United States
- University of Texas Science Center at San Antonio (uthscsa)
San Antonio, Texas, United States
- Us Oncology - Texas Oncology - Tyler
Tyler, Texas, United States
- Us Oncology - Virginia Cancer Specialists (vcs)
Fairfax, Virginia, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Dec 2016
- Primary completion
- 29 Jun 2022
- Completion
- 29 Jun 2022
- Last update posted
- 14 Nov 2023
- Registered enrollment
- 177
- Registry id
- NCT02729298
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.